- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
GE Web site educates about breast cancer
GE Medical Systems is collaborating with a half-dozen healthcare and cancer resource agencies to roll out a Web site for women who want information about breast care and cancer.The site, www.herSource.com, was unveiled at a press conference in February
GE Medical Systems is collaborating with a half-dozen healthcare and cancer resource agencies to roll out a Web site for women who want information about breast care and cancer.
The site, www.herSource.com, was unveiled at a press conference in February along with the Senographe 2000D, GEs full-field digital mammography unit that has since gained FDA clearance (SCAN 3/15/00). Digital mammography and the Senographe 2000D are featured in the sites treatment section, along with MR, ultrasound, and PET information.
Diagnostic and treatment information on the site will extend beyond radiology in the future, said Janet Lippincott, manager of www.herSource.com.
We are trying to make sure people are aware of all different types of procedures, she said.
Users can also find breast cancer statistics, definitions associated with the disease, a list of FDA-approved breast imaging centers, and financial information. Clinical information on the site is provided by the National Cancer Institute, the FDA, and other sources.
A disclaimer reads that GE cannot provide site users with medical advice, but patients can use www.herSource.com to link up with an interactive consultant on a Web site run by the U.S. Department of Defense, which has a medical research component. The Department of Defense funded development of the link, titled the Breast Cancer Decision Guide, where women with pathology and biopsy reports can obtain more information about the results.
The Web site is paid for by GE Medical Systems, which envisions it as a nonprofit venture. In addition, GE has plans to construct more Web sites that explore other healthcare issues in the future, said Tesha Urban, GE spokesperson.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
